Atrial Fibrillation and Risk of Clinical Events in Chronic Heart Failure With and Without Left Ventricular Systolic Dysfunction
Results From the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) Program
Lars G. Olsson, MB*,
Karl Swedberg, MD, PhD, FACC*,*,
Anique Ducharme, MD, MSc ,
Christopher B. Granger, MD, FACC ,
Eric L. Michelson, MD, FACC ,
John J.V. McMurray, MD, FACC||,
Margareta Puu, PhD¶,
Salim Yusuf, MD, DPhil, FACC#,
Marc A. Pfeffer, MD, PhD, FACC** on behalf of the CHARM Investigators
* Department of Medicine, Sahlgrenska University Hospital/Östra, Göteborg, Sweden
Research Center, Montreal Heart Institute, Montreal, Quebec, Canada
Duke University Medical Center, Durham, North Carolina
AstraZeneca LP, Wilmington, Delaware
|| Department of Cardiology, Western Infirmary, Glasgow, Scotland
¶ AstraZeneca, Mölndal, Sweden
# HGM-McMaster Clinic, Hamilton, Ontario, Canada
** Brigham and Women's Hospital, Boston, Massachusetts

View larger version (27K):
[in a new window]
|
Figure 1 Risk of baseline atrial fibrillation (AF) for cardiovascular (CV) events depending on ejection fraction (EF). CHF = chronic heart failure.
|
|

View larger version (14K):
[in a new window]
|
Figure 2 Time to cardiovascular (CV) death or hospitalization because of heart failure. AF = atrial fibrillation; EF = ejection fraction; PEF = preserved left ventricular ejection fraction.
|
|

View larger version (14K):
[in a new window]
|
Figure 3 Time to all-cause mortality. AF = atrial fibrillation; CI = confidence interval; EF = ejection fraction; PEF = preserved left ventricular ejection fraction.
|
|

View larger version (28K):
[in a new window]
|
Figure 4 Risk of new-onset atrial fibrillation (AF) for cardiovascular (CV) events depending on ejection fraction (EF). CHF = chronic heart failure.
|
|

View larger version (23K):
[in a new window]
|
Figure 5 Treatment effects depending on baseline heart rhythm in CHARM-Overall. AF = atrial fibrillation; CHF = chronic heart failure; CV = cardiovascular.
|
|
|